Home

Critical Care

Brensocatib Proves Ineffective for Patients Hospitalized With COVID-19

By

Ron Goldberg

Publish Date October 6, 2022

A clinical trial in Britain explored whether treatment with brensocatib, a dipeptidyl peptidase-1 inhibitor, would improve COVID-19 outcomes.

Smoking

Bronchodilators Fail in Symptomatic Smokers With Preserved Lung Function

By

Ron Goldberg

Publish Date October 6, 2022

A clinical trial assessed the benefit of inhaled bronchodilator therapy for symptomatic individuals with a 10-pack-year smoking history, preserved lung function, and no COPD.

Influenza

CDC Warns of Possible Severe Influenza Season Ahead

Publish Date October 6, 2022

Australia is experiencing its worst flu season in five years, and that does not bode well for the United States, federal health officials warned Tuesday.

Critical Care

D-Dimer Levels Have Limited Value in Identifying Pulmonary Embolism in COVID-19

By

melissaalvarez

Publish Date October 5, 2022

Researchers explored the use of D-dimer levels to rule out PTE in patients with COVID-19, as well as clinical associations between D-dimer levels and PTE.

Restrictive Lung Disease

Pirfenidone Benefits Patients With Arthritis-Associated Interstitial Lung Disease

By

Bradley van Paridon

Publish Date October 5, 2022

A phase 2 trial of pirfenidone for patients with RA-ILD yielded findings on the drug’s efficacy, safety, and tolerability, despite early termination of the trial.

Lung Cancer

Adjuvant Pembrolizumab Prolongs DFS in Resected Non-Small Cell Lung Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date October 5, 2022

Pembrolizumab is a potential new treatment option for stage IB-IIIA non-small cell lung cancer after complete resection, according to researchers.

Smoking

Exposure to Advertising Tied to Teen E-Cigarette Use

Publish Date October 5, 2022

Both electronic cigarette advertising and peer influence are significantly associated with e-cigarette initiation among U.S. teens.

Practice Management

Medicare Eligibility Linked to Improvements in Health Care Access

Publish Date October 5, 2022

Medicare eligibility and enrollment at age 65 years is associated with improvements in some measures of health care access and affordability.

COPD

Pulmonary Rehabilitation for COPD Has Greater Effect Coupled With Triple Therapy

By

Colby Stong

Publish Date October 4, 2022

How does inpatient pulmonary rehabilitation affect patients with severe COPD — and does the effect differ in those who use inhaled triple therapy?

Asthma

Subcutaneous Immunotherapy Safe, Effective in Pediatric Allergic Rhinitis/Asthma

By

Ron Goldberg

Publish Date October 4, 2022

How often does subcutaneous allergen-specific immunotherapy result in adverse reactions, what risk factors are associated with adverse reactions, and how effective is SCIT?